Company intelligence / Profile preview

Nurofen

Slough, Berkshire, United Kingdom
Ownership
Private
Employees
~40000
Development stage
Other
01

Overview

Reckitt is a global leader in consumer health and hygiene, and is the parent company of the widely recognized analgesic brand Nurofen. Nurofen, which utilizes ibuprofen as its active pharmaceutical ingredient, is one of the world's most popular over-the-counter pain relief medications. Originally developed by Boots and launched in 1983, the brand was acquired by Reckitt Benckiser in 2006 as part of a strategic expansion into the healthcare sector. Reckitt markets Nurofen in a variety of specialized formats, including liquid capsules, tablets, and pediatric suspensions, to address diverse needs such as tension headaches, muscular pain, and fever. The company continues to invest in the brand through innovations in drug delivery and fast-acting formulations. Beyond Nurofen, Reckitt's extensive health portfolio includes other major brands like Mucinex, Gaviscon, and Strepsils.

Therapeutic areas
NeurologyRheumatologyOtherInfectious DiseasesWomen's HealthImmunology
Modalities
Small molecule
Industry
Pharma

Beyond the preview

Go deeper on Nurofen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nurofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call